Search This Blog

Friday, May 6, 2022

Vertex Pharma cut to Neutral from Outperform by Baird

 Target $250

https://finviz.com/quote.ashx?t=VRTX&ty=c&ta=1&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.